Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Liselotte

Liselotte Brix, Bagsvaerd DK

Patent application numberDescriptionPublished
20100168390MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE - The present invention describes novel methods to generate MHC multimers and methods to improve existing and new MHC multimers. The invention also describes improved methods for the use of MHC multimers in analysis of T-cells in samples including diagnostic and prognostic methods. Furthermore the use of MHC multimers in therapy are described, e.g. anti-tumour and anti-virus therapy, including isolation of antigen specific T-cells capable of inactivation or elimination of undesirable targeT-cells or isolation of specific T-cells capable of regulation of other immune cells.07-01-2010
20100226854MHC Peptide Complexes and Uses Thereof in Infectious Diseases - Novel compounds carrying ligands capable of binding to counter receptors on relevant target cells are disclosed. The compounds possess a number of advantageous features, rendering them very suitable for a wide range of applications, including use as detection systems, detection of relevant target cells as well as a number of other methods. In particular, novel MHC complexes comprising one or more MHC molecules are disclosed. The affinity and specificity of the MHC-peptide complexes are surprisingly high. The possibility of presenting to the target cells a plurality of MHC-peptide complexes makes the MHC complexes according to the present invention an extremely powerful tool e.g. in the field of therapy and diagnosis. The invention generally relates to the field of therapy, including therapeutic methods and therapeutic compositions. Also comprised by the present invention is the sample-mounted use of MHC complexes and MHC multimers.09-09-2010
20100248257Compiled Methods for Analysing and Sorting Samples - The present invention relates to the fields of analysis, diagnostics, prognostics, standardization, characterization and enumeration of entities such as biological cells, as well as therapeutical applications. Accordingly, the present invention in preferred aspects is directed to methods for the detection and/or analysis and/or isolation and optionally further manipulation of entities, such as cells, particles, and supra-molecular structures.09-30-2010

Liselotte Hansen, Herlev DK

Patent application numberDescriptionPublished
20110201639STABILIZED TACROLIMUS COMPOSITION - The invention relates to a stable pharmaceutical composition comprising comprising a solid dispersion of tacrolimus in a vehicle further comprising a stabilizing agent capable of providing a pH below 7 in the composition, as measured after re-dispersion in water, and preventing or reducing the formation upon storage of major degradation products of tacrolimus, in particular the 8-epitacrolimus.08-18-2011

Liselotte Kaiser, Stockholm SE

Patent application numberDescriptionPublished
20090156427Bio-Sensing Nanodevice - The invention provides a bio-sensing nanodevice comprising: a stabilized biologically-derived G-protein coupled receptor—the olfactory receptor—on a support, a real time receptor-ligand binding detection method, an odorant delivery system and an odorant recognition program. The biologically-derived G-protein coupled receptor can be stabilized on nanotechnology using surfactant peptide. The said nanodevice provides a greater surface area for better precision and sensitivity to odorant detection. The invention further provides a microfluidic chip containing a stabilized biologically-derived G-protein coupled receptor—the olfactory receptor—immobilized on a support, and arranged in at least two dimensional microarray system. The invention also provides a method of delivering odorant comprising the step of manipulating the bubbles in complex microfluidic networks wherein the bubbles travel in a microfluidic channel carrying a variety of gas samples to a precise location on a chip. The invention further provides method of fabricating hOR17-4 olfactory receptor.06-18-2009

Liselotte Öhberg, Sodertalje SE

Patent application numberDescriptionPublished
20090131468Bis-(Sulfonylamino) Derivatives in Therapy 065 - The invention provides compounds of formula05-21-2009
20090281138Bis-(Sulfonylamino) Derivatives in Therapy 066 - The invention provides compounds of formula11-12-2009
20100292279Bis-(Sulfonylamino) Derivatives in Therapy - The invention provides compounds of formula11-18-2010
20110021540Bis-(Sulfonylamino) Derivatives in Therapy 066 - The invention provides compounds of formula wherein R01-27-2011
20110059992New Compounds - This invention relates to novel compounds having the structural formula I below:03-10-2011

Patent applications by Liselotte Öhberg, Sodertalje SE

Liselotte Öhberg, Sodertalje SE

Patent application numberDescriptionPublished
20100292279Bis-(Sulfonylamino) Derivatives in Therapy - The invention provides compounds of formula11-18-2010
20110059992New Compounds - This invention relates to novel compounds having the structural formula I below:03-10-2011